Safety of bronchodilator reversibility test in elderly subjects: a prospective study.

Introduction: The reversibility test measures an increase in ventilation parameters after the administration of 400 mg of a short-acting β-agonist (SABA). It is worth noting that a typical dosage, applied as a rescue medicine for bronchospastic dyspnoea, is significantly less, i.e.

Skin disorders in elderly subjects.

Background: Skin problems in the elderly population have rarely been the subject of scientific research.

Objectives: The present study aimed to determine the prevalences of the most common dermatological conditions in elderly subjects and to investigate their associations with systemic diseases.

Methods: The study involved a group of 198 consecutive patients aged ≥ 65 years who were admitted to the Departments of Dermatology and Geriatrics at the study institution.

Chronic disease in the elderly: a vital rationale for the revival of internal medicine.

The phenomenon of population aging has led to a significant rise in the chronic disease rate compared to other human pathologies. Elderly people are usually affected by > or =2 chronic diseases concomitantly, mainly cardiovascular, pulmonary, and central nervous system diseases, metabolic disturbances and cancer. Chronic comorbidities in elderly patients may worsen their clinical status, making both the diagnosis and treatment more difficult.

[The diagnostic differences of asthma in the elderly].

Asthma is a common disease among elderly persons. The prevalence of asthma in subjects aged over 65 years is 6.5-17%.

[The relationships between aging and disease in the elderly asthma].

In developed countries, the population aged 65 and over has been increasing. Asthma is a common disease among older persons and it may appear de novo above the age of 65. The prevalence of the disease in elderly people is estimated to be between 6.